Issue 24 of Multiple Myeloma Research Review.
Highlights include:
- Is MRD the best predictor of response?
- ctDNA and risk of distant relapse.
- Cardiac safety of bortezomib.
- Cytogenic evolution in relapsed MM.
Research Review: Multiple Myeloma – Issue 24
